Official UK procurement notice
Immunology Managed Service Contract · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Aug 2022)
Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)
What is being bought
Published requirement descriptionBCUHB is seeking to appoint a suitably qualified provider to deliver bespoke In Vitro Diagnostics support in delivering Immunology services on the Ysbyty Gwynedd site. This will include equipment, maintenance, consumables, reagents, information technology and training by way of managed service contract
CPV: Pathology services
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Closed
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 22 Aug 2022, 10:16 BST
- Last source update
- 22 Aug 2022, 10:16 BST
- Authority reference
BCU-OJEU-48997- FTS notice number
2022/S 000-023220- Classification (CPV)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-036151Find a Tender
How it was run
Official notice- Submission deadline
- 14 Oct 2022, 12:00 BST
Timeline
22 Aug 2022 → 14 Oct 2022 · 2 dates- Notice published22 Aug 2022, 10:16 BST
- Submission deadline14 Oct 2022, 12:00 BST
Notice history
1 release on Find a TenderPublished amendments (1 · 1 deadline change)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineTime limit · IV.2.2 | 30 Sept 2022 | 14 Oct 2022 | +14 d |
| — | Bid openingConditions for opening of tenders · IV.2.7 | 30 Sept 2022 | 14 Oct 2022 | +14 d |
It has been raised that one of the essential assay, Tryptase, is only available from one provider. Therefore, in order to ensure full transparency and fairness, the specification has now been amended to make Tryptase an Desirable Assay. This will not be included within the commercial scoring, however the Health Board would encourage bidders to provide a solution for this assay in the desirable sec…
Contracting authority & participating public bodies
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.